AKT1 and breast cancer: Our study suggests that mitochondrial dynamics and function could be enhanced in 3D cultured breast cancer stem cell spheres, and that the AKT inhibitor AZD5363 has the potential to suppress stemness, and re-sensitizing BCSCs to chemo drugs by regulating mitochondrial fusion.